Ab externo canaloplasty for primary open-angle glaucoma (IPG591)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 13 September 2017
Abicipar pegol for treating wet age-related macular degeneration ID1533Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ab interno canaloplasty for open-angle glaucoma (IPG745)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 November 2022
Adalimumab and dexamethasone for treating non-infectious uveitis (TA460)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 July 2017
AdenoPlus point-of-care test for diagnosing adenoviral conjunctivitis (MIB46)Product type:AdviceProgramme:Medtech innovation briefingPublished: 15 December 2015
Adults with lifelong or very severe hearing or visual impairment: health, well-being and social careStatus:Awaiting developmentExpected publication date: TBC
Aflibercept for treating choroidal neovascularisation (TA486)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 1 November 2017
Aflibercept for treating diabetic macular oedema (TA346)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 22 July 2015
Aflibercept for treating visual impairment caused by macular oedema after branch retinal vein occlusion (TA409)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 28 September 2016
Aflibercept for treating visual impairment caused by macular oedema secondary to central retinal vein occlusion (TA305)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 26 February 2014
Aflibercept for untreated diabetic macular oedema TS ID 10621Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Aflibercept for untreated retinopathy in babies born preterm TS ID 11943Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Aflibercept solution for injection for treating wet age‑related macular degeneration (TA294)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 24 July 2013
Age-related macular degeneration (NG82)Product type:GuidanceProgramme:NICE guidelinePublished: 23 January 2018
AI in retinal scanning MT524 (MIB265)Status:Topic selectionProgramme:Medical technologies guidanceExpected publication date: TBC
AI technologies for detecting diabetic retinopathy (MIB265)Product type:AdviceProgramme:Medtech innovation briefingPublished: 6 July 2021
Arteriovenous crossing sheathotomy for branch retinal vein occlusion (IPG334)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 March 2010
Artificial iris insertion for acquired aniridia (IPG674)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 July 2020
Artificial iris insertion for congenital aniridia (IPG675)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 July 2020
Avacincaptad pegol for treating geographic atrophy caused by age-related macular degeneration [ID6401]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Bevacizumab gamma for treating wet age-related macular degeneration [ID6320]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 4 December 2024
Bimatoprost implant for treating open angle glaucoma or ocular hypertension when topical treatments are unsuitable [ID6180]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Boston Keratoprosthesis Type I for corneal blindness (MIB91)Product type:AdviceProgramme:Medtech innovation briefingPublished: 18 January 2017
Botaretigene sparoparvovec for treating RPGR mutation-associated X-linked retinitis pigmentosa TS ID 10592Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Brolucizumab for treating diabetic macular oedema (TA820)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 31 August 2022
Brolucizumab for treating wet age-related macular degeneration (TA672)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 3 February 2021
Cataracts in adults: management (NG77)Product type:GuidanceProgramme:NICE guidelinePublished: 26 October 2017
Ciclosporin for treating dry eye disease that has not improved despite treatment with artificial tears (TA369)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 16 December 2015
Ciclosporin ophthalmic solution for treating dry eyes after inadequate response to artificial tears TSID8472Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
Corneal endothelial transplantation (IPG304)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 June 2009
Corneal implants for keratoconus (IPG227)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 July 2007
Corneal implants for the correction of refractive error (IPG225)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 July 2007
Corneal inlay implantation for correction of presbyopia (IPG455)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 April 2013
Dexamethasone intracanalicular insert for treating inflammation and pain after cataract surgery ID1154Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Dexamethasone intravitreal implant for the treatment of macular oedema secondary to retinal vein occlusion (TA229)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 July 2011
Dexamethasone intravitreal implant for treating diabetic macular oedema (TA824)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 14 September 2022
Diabetic retinopathy: management and monitoring (NG242)Product type:GuidanceProgramme:NICE guidelinePublished: 13 August 2024
Endoscopic dacryocystorhinostomy (IPG113)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 February 2005
Epiretinal brachytherapy for wet age-related macular degeneration (IPG415)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 16 December 2011
Faricimab for treating diabetic macular oedema (TA799)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 June 2022
Faricimab for treating visual impairment caused by macular oedema after retinal vein occlusion (TA1004)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 11 September 2024
Faricimab for treating wet age-related macular degeneration (TA800)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 29 June 2022
Fluocinolone acetonide intravitreal implant for treating chronic diabetic macular oedema (TA953)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 13 March 2024
Fluocinolone acetonide intravitreal implant for treating recurrent non-infectious uveitis (TA590)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 31 July 2019
Glaucoma: diagnosis and management (NG81)Product type:GuidanceProgramme:NICE guidelineLast updated: 26 January 2022Published: 1 November 2017
Glaucoma - lerdelimumab (CAT-152) [ID383]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
High-dose aflibercept for treating wet age-related macular degeneration TS ID 10590Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
High-intensity focused ultrasound for glaucoma (IPG661)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 September 2019
Holoclar for treating limbal stem cell deficiency after eye burns (TA467)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 16 August 2017
Icare rebound tonometer to measure intraocular pressure (MIB57)Product type:AdviceProgramme:Medtech innovation briefingPublished: 15 March 2016
Idebenone for treating visual impairment in Leber’s hereditary optic neuropathy in people 12 years and over [ID547]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 23 April 2025
Implantation of accommodating intraocular lenses for cataract (IPG209)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 February 2007
Implantation of a corneal graft–keratoprosthesis for severe corneal opacity in wet blinking eyes (IPG534)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 November 2015
Implantation of an opaque intraocular lens for intractable double vision (IPG293)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 March 2009
Implantation of multifocal (non-accommodative) intraocular lenses during cataract surgery (IPG264)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 June 2008
Inebilizumab for treating AQP4-IgG seropositive neuromyelitis optica spectrum disorders ID6430Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Insertion of an epiretinal prosthesis for retinitis pigmentosa (IPG519)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 June 2015
Insertion of a subretinal prosthesis system for retinitis pigmentosa (IPG537)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 16 December 2015
Insertion of hydrogel keratoprosthesis (IPG69)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 June 2004
Intraocular lens insertion for correction of refractive error, with preservation of the natural lens (IPG289)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 February 2009
Laser correction of refractive error following non-refractive ophthalmic surgery (IPG385)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 23 March 2011
Latanoprost–netarsudil for previously treated primary open-angle glaucoma or ocular hypertension (TA1009)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 2 October 2024
Lateral orbital decompressionStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Lenadogene nolparvovec for treating Leber's hereditary optic neuropathy caused by the G11778A ND4 mitochondrial mutation [ID1410]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Limited macular translocation for wet age-related macular degeneration (IPG339)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 19 May 2010
LipiFlow thermal pulsation treatment for dry eyes caused by blocked meibomian glands (MIB29)Product type:AdviceProgramme:Medtech innovation briefingPublished: 21 April 2015
Macular translocation with 360° retinotomy for wet age-related macular degeneration (IPG340)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 19 May 2010
Microinvasive subconjunctival insertion of a trans-scleral gelatin stent for primary open-angle glaucoma (IPG612)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 April 2018
Miniature lens system implantation for advanced age-related macular degeneration (IPG565)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 September 2016
Miniature lens system implantation for advanced age-related macular degenerationStatus:Topic selectionProgramme:Interventional procedures guidanceExpected publication date: TBC
Nerve graft for corneal denervation (IPG729)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 29 June 2022
Netarsudil for treating open angle glaucoma or ocular hypertension [ID1078]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Noctura 400 Sleep Mask for diabetic retinopathy and diabetic macular oedema (MIB144)Product type:AdviceProgramme:Medtech innovation briefingPublished: 24 April 2018
NVK-002 for treating myopia in people 3 to 17 years TSID 11961Status:Topic selectionProgramme:Technology appraisal guidanceExpected publication date: TBC
ORA G3 to measure corneal hysteresis (MIB150)Product type:AdviceProgramme:Medtech innovation briefingPublished: 18 June 2018
Pegcetacoplan for treating geographic atrophy [ID4041]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Photochemical corneal collagen cross‑linkage using riboflavin and ultraviolet A for keratoconus and keratectasia (IPG466)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 September 2013
Photorefractive (laser) surgery for the correction of refractive errors (IPG164)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 March 2006
Phototherapeutic laser keratectomy for corneal surface irregularities (IPG358)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 September 2010
Polyhexanide eye drops for treating acanthamoeba keratitis in people 12 years and over [ID6497]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Port Delivery System with ranibizumab for treating wet age-related macular degeneration [ID3983]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Radiotherapy for age-related macular degeneration (IPG49)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 24 March 2004
Ranibizumab and pegaptanib for the treatment of age-related macular degeneration (TA155)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 20 May 2024Published: 27 August 2008
Ranibizumab for treating choroidal neovascularisation associated with pathological myopia (TA298)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 20 May 2024Published: 27 November 2013
Ranibizumab for treating diabetic macular oedema (TA274)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 26 October 2023Published: 27 February 2013
Ranibizumab for treating visual impairment caused by macular oedema secondary to retinal vein occlusion (TA283)Product type:GuidanceProgramme:Technology appraisal guidanceLast updated: 20 May 2024Published: 22 May 2013
Ranibizumab port delivery system for treating diabetic macular oedema ID6137Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Ravulizumab for treating AQP4 antibody-positive neuromyelitis optica spectrum disorder (terminated appraisal) (TA941)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 20 December 2023
Repetitive short-pulse transscleral cyclophotocoagulation for glaucoma (IPG692)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 April 2021
Retrobulbar irradiation for thyroid eye disease (IPG148)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 14 December 2005
Satralizumab for preventing relapses in neuromyelitis optica spectrum disorders (terminated appraisal) (TA960)Product type:GuidanceProgramme:Technology appraisal guidancePublished: 27 March 2024
Scleral expansion surgery for presbyopia (IPG70)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 28 July 2004
TearLab osmolarity system for diagnosing dry eye disease (MIB47)Product type:AdviceProgramme:Medtech innovation briefingPublished: 15 December 2015
Tebentafusp for treating advanced (unresectable or metastatic) uveal melanoma [ID1441]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tenotomy of horizontal eye muscles for nystagmus (with reattachment at their original insertions) (IPG299)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 May 2009
Teprotumumab for treating thyroid eye disease [ID6432]Status:In developmentProgramme:Technology appraisal guidanceExpected publication date: 20 August 2025
The SENSIMED Triggerfish contact lens sensor for continuous 24-hour recording of ocular dimensional changes in people with or at risk of developing glaucoma (MIB14)Product type:AdviceProgramme:Medtech innovation briefingPublished: 19 November 2014
Timrepigene emparvovec for treating choroideremia [ID3916]Status:Awaiting developmentProgramme:Technology appraisal guidanceExpected publication date: TBC
Tissue-cultured limbal stem cell allograft transplantation for regrowth of corneal epithelium (IPG216)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 April 2007
Trabecular stent bypass microsurgery for open-angle glaucoma (IPG575)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 22 February 2017
Trabeculectomy with a biodegradable collagen matrix implant for glaucoma (IPG750)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 17 January 2023
Trabeculotomy ab interno for open angle glaucoma (IPG397)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 25 May 2011
Transpupillary thermotherapy for age-related macular degeneration (IPG58)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 27 May 2004
Voretigene neparvovec for treating inherited retinal dystrophies caused by RPE65 gene mutations (HST11)Product type:GuidanceProgramme:Highly specialised technologies guidancePublished: 9 October 2019
YAG laser vitreolysis for symptomatic vitreous floaters (IPG741)Product type:GuidanceProgramme:Interventional procedures guidancePublished: 26 October 2022